How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

16,911 results for

HIV Course

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

15961. The cost effectiveness of a single-dose nevirapine regimen to mother and infant to reduce vertical HIV-1 transmission in sub-Saharan Africa

Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The authors considered treatments to reduce the vertical transmission of human immunodeficiency virus type 1 (HIV-1) from mother to child. The treatments considered include an "ultra (...) PubMedID Other publications of related interest Guay LA, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda. Lancet 1999;354:795-802. Leroy V, Newell ML, Dabis F, et al. International multicentre pooled analysis of late postnatal mother-to-child transmission of HIV-1 infection. Lancet;352:597-600. Indexing Status Subject indexing assigned by NLM MeSH Acquired Immunodeficiency

2000 NHS Economic Evaluation Database.

15962. The cost-effectiveness of the WINGS intervention: a program to prevent HIV and sexually transmitted diseases among high-risk urban women

of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The health intervention examined was the Women in Group Support (WINGS) project for urban heterosexual women at risk of acquiring human immunodeficiency virus (HIV) and other sexually transmitted diseases (STDs). This was a 6-session (...) , they ranged from $27,506 to $1,635,740 with the complete intervention and from cost-saving values to $783,820 with the CUSC. The lower and upper bounds reported represented the 5th and 95th percentiles of the cost-effectiveness ratios generated in the Monte Carlo simulations. Authors' conclusions The human immunodeficiency virus (HIV) prevention programme, in particularly the condom use skills component (CUSC), was below the critical threshold of $50,000 per quality-adjusted life-year (QALY) gained when

2002 NHS Economic Evaluation Database.

15963. Effectiveness of standard short-course chemotherapy for treating tuberculosis and the impact of drug resistance on its outcome

of Mycobacterium tuberculosis and susceptibility test results were eligible for inclusion. Most of the studies included civilian TB patients; however, one study included prisoners and one study included gold miners infected with the human immunodeficiency virus. The majority of the included studies were conducted in Asia, while the others were conducted in Europe, North America and South Africa; one study was conducted in six different countries. Outcomes assessed in the review The outcomes of interest were (...) Effectiveness of standard short-course chemotherapy for treating tuberculosis and the impact of drug resistance on its outcome Effectiveness of standard short-course chemotherapy for treating tuberculosis and the impact of drug resistance on its outcome Effectiveness of standard short-course chemotherapy for treating tuberculosis and the impact of drug resistance on its outcome Han T CRD summary This well-conducted review assessed standard short-course chemotherapy for patients

2006 DARE.

15964. Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a cost-effectiveness analysis based on a multicenter clinical trial Full Text available with Trip Pro

of isoniazid (IS) for the treatment of latent tuberculosis (TB) infection in adults without human immunodeficiency virus (HIV) infection. Type of intervention Treatment. Economic study type Cost-effectiveness analysis. Study population The study population comprised adults aged 17 years or older with a positive tuberculin skin test result (defined by ATS/CDC criteria), in whom active TB was excluded, and in whom treatment of latent TB infection would ordinarily be recommended (e.g. close contact (...) with no treatment. For latent TB infection in adults without human immunodeficiency virus (HIV) infection, treatment with IS for 6 months was more cost-effective than R-Z for 2 months. CRD COMMENTARY - Selection of comparators Both interventions assessed in the analysis had been recommended, by US national guidelines, for the treatment of latent TB infection in adults without HIV infection. The comparator of the analysis (IS for 6 months) was selected because it represented the standard treatment for decades

2004 NHS Economic Evaluation Database.

15965. Summary of clinical standards for acquired syphilis in HIV-positive patients

. Erythromycin is not recommended because of poor CSF penetration. Need for lumbar puncture • All HIV-infected patients with positive syphilis serology must have a full documented neurological examination. If neurological symptoms or signs are present, a head scan and lumbar puncture is required to exclude other HIV related conditions. Asymptomatic HIV positive patients do not require a lumbar puncture unless they are going to be treated with a course of antibiotics where there is uncertainty about whether (...) Summary of clinical standards for acquired syphilis in HIV-positive patients Draft v.8 21.2.02 IMPORTANT INFORMATION FOR ALL CLINICIANS INVOLVED IN THE CARE OF INDIVIDUALS WITH HIV INFECTION SUMMARY OF CLINICAL STANDARDS FOR ACQUIRED SYPHILIS IN HIV-POSITIVE ADULTS This document has been produced as a response to outbreaks of syphilis in the UK, predominantly amongst men who have sex with men and with a high rate of concomitant HIV infection. Reference should be made to the full supporting

2002 British Association for Sexual Health and HIV

15966. Clinical standards & management of acquired syphilis in HIV-positive patients

disease and human immunodeficiency virus screening guidelines for men who have sex with men. Sex Transm Dis 2001; in press and at www.metrkc.gov/health/apu/std 15.California Sexually Transmitted Disease Controllers Association. Guidance for STD clinical preventive services for persons infected with HIV. Sex Transm Dis 2001; in press.Draft v.8 21.2.02 Page 9 16. CDSC. Increased transmission of syphilis in Brighton and Greater Manchester among men who have sex with men. Commun Dis Rep CDR Wkly 2000;10 (...) (43):383-386. 17. Becerra LI, Ksiazek SM, Savino PJ, et al. Syphilitic uveitis in human immunodeficiency virus-infected and non-infected patients. Ophthalmology 1989;96:1727- 1730. 18. Berger JR. Neurosyphilis in human immunodeficiency virus type 1-seropositive individuals. Arch Neurol 1991;48:700-702. 19. Bordon J, Martinez-Vazquez C, Alvarez M, et al: Neurosyphilis in HIV-infected patients. Eur J Clin Microbiol Infect Dis 1995;14:864-869. 20. Nandwani R, Evans DTP. Are you sure it’s syphilis

2002 British Association for Sexual Health and HIV

15967. HIV prevention in Mexican schools: prospective randomised evaluation of intervention. Full Text available with Trip Pro

HIV prevention in Mexican schools: prospective randomised evaluation of intervention. To assess effects on condom use and other sexual behaviour of an HIV prevention programme at school that promotes the use of condoms with and without emergency contraception.Cluster randomised controlled trial.40 public high schools in the state of Morelos, Mexico.10 954 first year high school students.Schools were randomised to one of three arms: an HIV prevention course that promoted condom use, the same (...) course with emergency contraception as back-up, or the existing sex education course. Self administered anonymous questionnaires were completed at baseline, four months, and 16 months. Students at intervention schools received a 30 hour course (over 15 weeks) on HIV prevention and life skills, designed in accordance with guidelines of the joint United Nations programme on HIV/AIDS. Two extra hours of education on emergency contraception were given to students in the condom promotion

2006 BMJ Controlled trial quality: uncertain

15968. Single-dose tenofovir and emtricitabine for reduction of viral resistance to non-nucleoside reverse transcriptase inhibitor drugs in women given intrapartum nevirapine for perinatal HIV prevention: an open-label randomised trial. (Abstract)

this complication would be reduced with a single peripartum intervention of tenofovir and emtricitabine.We randomly assigned 400 HIV-infected pregnant women who sought care at two public-sector primary health facilities in Lusaka, Zambia. One was excluded, 200 were assigned to receive a single oral dose of 300 mg tenofovir disoproxil fumarate with 200 mg emtricitabine under direct observation, and 199 to receive no study drug. Short-course zidovudine and intrapartum nevirapine were offered to all HIV-infected (...) Single-dose tenofovir and emtricitabine for reduction of viral resistance to non-nucleoside reverse transcriptase inhibitor drugs in women given intrapartum nevirapine for perinatal HIV prevention: an open-label randomised trial. Intrapartum and neonatal single-dose nevirapine are essential components of perinatal HIV prevention in resource-constrained settings, but can induce resistance to other non-nucleoside reverse transcriptase inhibitor drugs. We aimed to investigate whether

2007 Lancet Controlled trial quality: predicted high

15969. Role of depression, stress, and trauma in HIV disease progression Full Text available with Trip Pro

Role of depression, stress, and trauma in HIV disease progression Despite advances in HIV treatment, there continues to be great variability in the progression of this disease. This paper reviews the evidence that depression, stressful life events, and trauma account for some of the variation in HIV disease course. Longitudinal studies both before and after the advent of highly active antiretroviral therapies (HAART) are reviewed. To ensure a complete review, PubMed was searched for all English (...) language articles from January 1990 to July 2007. We found substantial and consistent evidence that chronic depression, stressful events, and trauma may negatively affect HIV disease progression in terms of decreases in CD4 T lymphocytes, increases in viral load, and greater risk for clinical decline and mortality. More research is warranted to investigate biological and behavioral mediators of these psychoimmune relationships, and the types of interventions that might mitigate the negative health

2008 EvidenceUpdates

15970. Trends in HIV-1 in young adults in south India from 2000 to 2004: a prevalence study. (Abstract)

Trends in HIV-1 in young adults in south India from 2000 to 2004: a prevalence study. Major increases in HIV-1 prevalence in India have been predicted. Incident infections need to be tracked to understand the epidemic's course, especially in some southern states of India where the epidemic is more advanced. To estimate incidence, we investigated the prevalence of HIV-1 in young people attending antenatal and sexually transmitted infection (STI) clinics in India.We analysed unlinked, anonymous (...) HIV-1 prevalence data from 294 050 women attending 216 antenatal clinics and 58 790 men attending 132 STI clinics in 2000-04. Southern and northern states were analysed separately.The age-standardised HIV-1 prevalence in women aged 15-24 years in southern states fell from 1.7% to 1.1% in 2000-04 (relative reduction 35%; p(trend)<0.0001, yearly reduction 11%), but did not fall significantly in women aged 25-34 years. Reductions in women aged 15-24 years were seen in key demographic groups and were

2006 Lancet

15971. What are the potential risks to nurses managing HIV/AIDS patients in the community, specifically; dressing pressure ulcers, re-catheterising and venepuncture?

with exposure to a larger quantity of blood from the source person as indicated by 1) a device (e.g., a needle) visibly contaminated with the patient’s blood, 2) a procedure that involved a needle being placed directly in a vein or artery, or 3) a deep injury. The risk also was increased for exposure to blood from source persons with terminal illness, possibly reflecting either the higher titer of HIV in blood late in the course of acquired immunodeficiency syndrome (AIDS) or other factors (e.g (...) fast’ and this is something we aim to deliver for every single search. As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news. For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com What are the potential risks to nurses managing HIV/AIDS patients

2006 TRIP Answers

15972. What are the survival rates for treated non-hodgkins lymphoma in patients without HIV?

types including images, videos, patient information leaflets, educational courses and news. For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com What are the survival rates for treated non-hodgkins lymphoma in patients without HIV? eMedicine has a chapter on non-hodgkins lymphoma [1] and this includes an extensive section on prognosis [2]. This section discusses (...) What are the survival rates for treated non-hodgkins lymphoma in patients without HIV? What are the survival rates for treated non-hodgkins lymphoma in patients without HIV? - Trip Database or use your Google+ account Liberating the literature ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches

2007 TRIP Answers

15973. What are the survival rates for treated non-hodgkins lymphoma in patients with HIV?

types including images, videos, patient information leaflets, educational courses and news. For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com What are the survival rates for treated non-hodgkins lymphoma in patients with HIV? We found relatively little on survival rates of NHL in patients with HIV. The charity website aidsmap reports [1]: “NHL among people (...) What are the survival rates for treated non-hodgkins lymphoma in patients with HIV? What are the survival rates for treated non-hodgkins lymphoma in patients with HIV? - Trip Database or use your Google+ account Turning Research Into Practice ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches

2007 TRIP Answers

15974. Are there any figures for HIV prevalence?

Are there any figures for HIV prevalence? Are there any figures for HIV prevalence? - Trip Database or use your Google+ account Liberating the literature ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches by placing the search numbers in the top search box and pressing the search button (...) users to quickly and easily find and use high-quality research evidence to support their practice and/or care. Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search. As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses

2007 TRIP Answers

15975. Are there any data to estimate risk of HIV transmission following a single episode of unprotected sexual intercourse if the infected partner is on sucessful treatment and has an undetectable viral loa

the virus. Conversely it is also known that urethritis increases seminal fluid HIV viral load. An uninfected individual is thought to be most at risk of acquiring HIV by unprotected receptive anal sex. There has also been increased recognition that oral sex alone carries a risk of HIV transmission as well as STIs such including syphilis (particularly in coinfected individuals).” [1] Page 15 of the guideline contains a table gives estimated risk of HIV transmission per exposure. A second BASHH guideline (...) on the secondary transmission of HIV among men who have sex with men, we used a previously published state-transition model of HIV disease to simulate the clinical and virologic course of HIV infection among 2 cohorts of men who have sex with men: (1) a cohort of individuals who were not receiving ART and (2) a cohort of individuals treated with US guideline-concordant ART. The model tracked the number of acts of unprotected insertive anal intercourse, transmission risk per act as determined by HIV RNA level

2007 TRIP Answers

15976. What general vacines should HIV positive patients have and how effective are they?

types including images, videos, patient information leaflets, educational courses and news. For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com What general vacines should HIV positive patients have and how effective are they? ATTRACT found several documents to guide practice in this area, which are too extensive to reproduce in their entirety. The following (...) What general vacines should HIV positive patients have and how effective are they? What general vacines should HIV positive patients have and how effective are they? - Trip Database or use your Google+ account Turning Research Into Practice ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches

2008 TRIP Answers

15977. A 30 year old man has had protected sex with a prostitute 1 week ago and is asking about HIV prophylaxis

clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news. For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com A 30 year old man has had protected sex with a prostitute 1 week ago and is asking about HIV prophylaxis The NLH Q&A Service are not in a position to answer 'should' type questions. We (...) A 30 year old man has had protected sex with a prostitute 1 week ago and is asking about HIV prophylaxis A 30 year old man has had protected sex with a prostitute 1 week ago and is asking about HIV prophylaxis - Trip Database or use your Google+ account Turning Research Into Practice ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere

2006 TRIP Answers

15978. HIV Antibody

HIV Antibody HIV Antibody and HIV Antigen Test Produced by In partnership with User Top Links Menu Search User Top Links Search HIV Antibody and HIV Antigen (p24) Also Known As HIV Screening Tests AIDS Test AIDS Screen HIV Serology p24 Antigen Formal Name Human immunodeficiency virus (HIV) antibody / antigen test This article was last reviewed on 16 February 2017. This article was last modified on 29 October 2017. At a Glance Why Get Tested? To determine if you are infected with When To Get (...) the reference range if you do not have the lab report. For more information on reference ranges, please read . What is being tested? infects the cells of a person’s immune system and is the cause of AIDS (acquired immunodeficiency syndrome). When a person becomes infected with HIV, through exposure to the blood or body fluids of an infected individual, the virus begins to reproduce very rapidly. So, during the first few weeks of infection, the amount of virus (viral load) in the blood can be quite high

2004 Lab Tests Online UK

15979. HIV Antibody

. Mayo Clinic Staff (2008 August 9). MayoClinic HIV/AIDS. MayoClinic.com [On-line information]. Available online at http://www.mayoclinic.com/health/hiv-aids/DS00005. Accessed on 10/30/08. (2005 November, Revised). Human Immunodeficiency Virus (HIV) Introduction. Merck Manual for Healthcare Professionals [On-line information]. Available online at http://www.merck.com/mmpe/sec14/ch192/ch192a.html?qt=HIV&alt=sh. Accessed on 10/30/08. (2008 September, Reviewed). Human Immunodeficiency VirusHIV. ARUP (...) the article . What is being tested? is the cause of AIDS (acquired immunodeficiency syndrome). HIV screening tests detect the HIV (p24) and/or HIV produced in response to an HIV infection in the blood. Some tests detect HIV antibody in oral fluid. When a person becomes infected with HIV, through exposure to the blood or body fluids of an infected individual or a contaminated needle, for example, the virus begins to replicate itself, producing a large number of copies. During the first few weeks

2004 Lab Tests Online USA

15980. Entecavir Intensification for Persistent HBV Viremia in HIV-HBV Infection

: A109324 AI463-162 First Posted: April 21, 2008 Results First Posted: May 16, 2013 Last Update Posted: May 27, 2013 Last Verified: May 2013 Keywords provided by University of California, San Francisco: HIV Hepatitis B treatment experienced Additional relevant MeSH terms: Layout table for MeSH terms Infection Communicable Diseases Hepatitis Hepatitis A HIV Infections Hepatitis B Viremia Liver Diseases Digestive System Diseases Hepatitis, Viral, Human Virus Diseases Enterovirus Infections Picornaviridae (...) Primary Endpoint: Mean log10 reduction of HBV DNA at 24 weeks of standard therapy vs. entecavir intensification. Study Design Go to Layout table for study information Study Type : Interventional (Clinical Trial) Actual Enrollment : 10 participants Allocation: Randomized Intervention Model: Parallel Assignment Masking: None (Open Label) Primary Purpose: Treatment Official Title: Entecavir Intensification for Persistent Hepatitis B Virus (HBV) Viremia in HIV-HBV Infection Study Start Date : April 2008

2008 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>